CARsgen Therapeutics Holdings Ltd. (HK:2171) has released an update.
CARsgen Therapeutics Holdings Ltd. announced a shareholding increase by YIJIE Biotech, a substantial shareholder, who has now acquired additional shares, raising their stake from approximately 37.45% to 37.78%. Moreover, the company has utilized its repurchase mandate to buy back 0.69% of its total issued shares using non-IPO funds, highlighting the shareholder’s confidence and the company’s commitment to sustaining its market value.
For further insights into HK:2171 stock, check out TipRanks’ Stock Analysis page.
